Clinical Outcomes of Chemotherapeutic Molecules as Single and Multiple Agents in Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Patients
Conclusions: The findings of this review indicate that targeted therapy using specific inhibitors is now the most promising first-line anticancer treatment available in the market. However, chemotherapy is still effective in treating advanced NSCLC and is viable as a first-line treatment.PMID:34833470 | PMC:PMC8618045 | DOI:10.3390/medicina57111252
Source: Medicina (Kaunas) - Category: Universities & Medical Training Authors: Ting Yoon Kwan Ezharul Hoque Chowdhury Source Type: research
More News: Alimta | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Study | Universities & Medical Training